News Conference News ACC 2026 Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate Todd Neale April 02, 2026
News Conference News ACC 2026 Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI Yael L. Maxwell March 30, 2026
News Daily News Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD Yael L. Maxwell March 24, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2026 Michael O'Riordan March 02, 2026
News Opinion Off Script Why Interventionalists Must Work Toward Global Cardiovascular Equity Tesfaye Telila, MD February 17, 2026
News Daily News Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass Yael L. Maxwell January 14, 2026
News Daily News CAC Predicts Obstructive CAD, but Thresholds Diverge by Sex L.A. McKeown January 06, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2025 Michael O'Riordan December 29, 2025
News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Daily News STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients Yael L. Maxwell December 05, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2025 Caitlin E. Cox December 01, 2025
News Daily News Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges Caitlin E. Cox November 21, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2025 Caitlin E. Cox November 03, 2025
News Conference News TCT 2025 Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE Caitlin E. Cox October 28, 2025
News Conference News TCT 2025 PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats Todd Neale October 28, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025